查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1461449

IPV 疫苗市场：按疫苗品牌、分销管道、地区 - 市场规模、份额、前景、机会分析，2024-2031 年

IPV Vaccines Market, by Vaccine Brand (POLIOVAC, SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球IPV疫苗市场规模为1.996亿美元，预测期间（2024-2031年）复合年增长率为8.5%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 1.996 亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024-2030/2031复合年增长率 8.50% 2030/2031 年预测值 3.524 亿美元
2024 年全球 IPV 疫苗市场规模（百万美元），按地区划分
IPV疫苗市场-IMG1

灭活脊髓灰质炎疫苗（IPV）也称为索尔克疫苗。脊髓灰质炎疫苗有两种：灭活脊髓灰质炎疫苗和口服脊髓灰质炎疫苗。 IPV 疫苗主要注射到手臂和腿部。

对鸡蛋或链霉素等药物过敏的人不应接受 IPV 注射。只有当接种疫苗的人正在接受长期类固醇治疗、患有癌症、正在接受化疗或家中有未免疫的成年人时，才会接种 IPV。

预计 2024 年全球 IPV 疫苗市值为 1.996 亿美元，到 2031 年将扩大到 3.524 亿美元，预测期内复合年增长率为 8.5%。

市场动态

为了预防脊髓灰质炎的爆发，各国政府已采取倡议提高人们对疫苗接种的认识。公共推出了有益的免疫计划，为穷人提供疫苗接种，预计这为全球灭活脊髓灰质炎疫苗市场（IPV）的成长创造了非常有利的环境。例如，2019年9月，加纳卫生服务局（GHS）启动了一系列脊髓灰质炎疫苗接种/免疫宣传活动，以防止病毒在高风险地区传播。脊髓灰质炎疫苗免疫宣传活动将使用灭活脊髓灰质炎疫苗（IPV）为加纳所有地区2016年1月至2018年6月期间出生的所有儿童进行免疫接种。

本研究的主要特点

  • 本报告详细分析了以2023年为基准年的预测期（2024-2031）全球IPV疫苗市场规模和年复合成长率（CAGR%）。
  • 它阐明了不同细分市场的潜在商机，并描述了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司简介、业绩、产品系列、市场影响、分销策略、关键发展、策略和未来计划等参数，介绍了全球 IPV 疫苗市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • IPV 疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
  • 透过用于分析全球 IPV 疫苗市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件

第二章 市场概况

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 市场机会蓝图

第 3 章主要见解

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • PEST分析
  • 波特分析
  • 公司市场占有率分析
  • 进出口分析
  • 监管场景
  • 价格分析
  • COVID-19 影响分析
  • 流行病学
  • 各国医疗费用支出
  • 按国家/地区分類的疫苗接种覆盖率
  • 製造能力
  • 经销商状况
  • 投资金筹措
  • 比赛简介
  • 热图分析

第四章2019-2031年全球IPV疫苗市场（以疫苗品牌）

  • 介绍
  • 脊髓灰质炎(PFS/SD)
  • 沙尼普
  • Orix
  • IPOL/伊莫瓦克斯
  • 聚灭蚁灵

第五章2019-2031年全球IPV疫苗市场（依疫苗类型）

  • 介绍
  • 联合疫苗
  • 单一疫苗

第六章 全球 IPV 疫苗市场，以管瓶型划分，2019-2031 年

  • 介绍
  • 单剂量管瓶
  • 5 剂管瓶
  • 10 剂管瓶

第7章2019-2031年全球IPV疫苗市场（依通路）

  • 介绍
  • 公共
  • 私人的

第八章2019-2031年全球IPV疫苗市场（按地区）

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 波湾合作理事会
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 竞争格局

第十章公司简介-全球IPV疫苗市场

  • Sanofi
  • 最新动态/更新
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Merck &Co., Inc.
  • GlaxoSmithKline
  • AJ Vaccines A/S
  • Panacea Biotec
  • Biken
  • Sinopharm Group Co. Ltd.
  • Nanolek
  • IMBCAMS
  • Sinovac Biotech
  • LG Chem
  • Beijing Minhai Biological Technology Co., Ltd.
  • Biological E Limited.
  • 升起和降落
  • 分析师观点
  • 综合机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4965

The global IPV vaccines market is estimated to be valued at USD 199.6 Mn in 2024 and is expected to exhibit a CAGR of 8.5% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 199.6 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 8.50% 2030/2031 Value Projection: US$ 352.4 Mn
Global IPV Vaccines Market Value (USD Mn), by Region, 2024
IPV Vaccines Market - IMG1

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.6 Mn in 2024 and is expected to increase to US$ 352.4 Mn by 2031, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

  • This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

  • Global IPV Vaccines Market, by Vaccine Brand:
    • Poliovac (Pfs/Sd)
    • Shanipv
    • Poliorix
    • Ipol/Imovax
    • Polymilex
  • Global IPV Vaccines Market, by Distribution Channel:
    • Private
    • Public
  • Global IPV Vaccines Market, by Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles:
    • GlaxoSmithKline Plc
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • PT Bio Farma
    • AJ Vaccines

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Brand
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Vial Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Company Market Share Analysis
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Epidemiology
  • Healthcare Spending, by Country
  • Vaccination Rate, by Country
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Competitive Snapshot
  • Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2019 - 2031 (US$ Million)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • POLIOVAC (PFS/SD), 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • SHANIPV, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • POLIORIX, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • IPOL/IMOVAX, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • POLYMILEX, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2019 - 2031 (US$ Million)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Combination Vaccine, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • Single Vaccine, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2019 - 2031 (US$ Million)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • 1 Dose Vial, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • 5 Dose Vial, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • 10 Dose Vial, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2019 - 2031 (US$ Million)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Public, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)
  • Private, 2019 - 2031(US$ Million)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2019 - 2031 (US$ Million)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Million)
    • Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Million)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Asean
  • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
  • GCC
  • Israel
  • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Million)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2024 - Global

10. Company Profiles - Global IPV Vaccines Market

  • Sanofi*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Merck & Co., Inc.
  • GlaxoSmithKline
  • AJ Vaccines A/S
  • Panacea Biotec
  • Biken
  • Sinopharm Group Co. Ltd.
  • Nanolek
  • IMBCAMS
  • Sinovac Biotech
  • LG Chem
  • Beijing Minhai Biological Technology Co., Ltd.
  • Biological E Limited.
  • Section 10: Wheel of Fortune
  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact